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2 
i Abstract 
2 Members of the Cronobacter genus (formerly Enterobacter sakazakii) have become associated with 
3 neonatal infections and in particular contaminated reconstituted infant formula. However this is only 
4 one perspective of the organism since the majority of infections are in the adult population, and the 
5 organism has been isolated from the enteral feeding tubes of neonates on non-formula diets. In recent 
6 years methods of detection from food and environmental sources have improved, though accurate 
7 identification has been problematic. The need for robust identification is essential in order to 
8 implement recent Codex Alimentarius Commission (2008) and related microbiological criteria for 
9 powdered infant formula (PIF; intended target age 0-6 months). Genomic analysis of emergent 
10 pathogens is of considerable advantage in both improving detection methods, and understanding the 
11 evolution of virulence. One ecosystem for Cronobacter is on plant material which may enable the 
12 organism to resist desiccation, adhere to surfaces, and resist some antimicrobial agents. These traits 
13 may also confer survival mechanisms of relevance in food manufacturing and also virulence 
14 mechanisms. 
15 
3 
i Introduction 
2 Food safety is important to everyone, and especially the highly vulnerable members of our society. 
3 This article concerns the bacterial genus Cronobacter which can cause severe illness in the highly 
4 vulnerable neonates, infants and the elderly. In recent years this group of organisms have gone from 
5 curiosity to notoriety and this article aims to deliver a balanced viewpoint on their importance and an 
6 overview of our knowledge 
7 Cronobacter is a genus within the Enterobacteriaceae family and is closely related to the 
8 Enterobacter and Citrobacter genera. It has come to prominence due to its association with severe 
9 neonatal infections (necrotizing enterocolitis, septicaemia and meningitis) which can be fatal. As 
10 neonates are frequently fed reconstituted PIF, which is not a sterile product, this potential vector has 
11 been the focus of attention for reducing infection risk to neonates as the number of exposure routes is 
12 limited. It should be noted however that such neonatal infections are rare, and not all have been 
13 associated with reconstituted formula ingestion. In fact (a) breast milk is also not sterile, (b) C. 
14 malonaticus L M G 23826T (type strain) was isolated from a breast abscess, (c) Cronobacter has been 
15 isolated from breast milk, (d) breast milk from mastic mothers is used to feed neonates, (e) the 
16 organism has been isolated from enteral feeding tubes from neonates on non-formula diets and (f) the 
17 majority of Cronobacter infections, albeit less severe, are in the adult population. 
18 To date the raised awareness of the organism has focussed on infant infections and resulted in changes 
19 in the microbiological criteria for PIF and reconstitution procedures. In other words, there have been 
20 required changes on two sides of the same coin; manufacturing practices and hygienic preparation 
21 practices. Such requirements need regulatory enforcement and support, but must be based on robust 
22 reliable information. Consequently there have been three FAOAVHO risk assessment meetings on the 
23 microbiological safety of PIF (FAOAVHO 2004, FAOAVHO 2006, FAOAVHO 2008). Those 
24 identified as being at high risk of Cronobacter infection are neonates (especially low birth weight) for 
25 whom their source of nutrition will be limited to breast milk, fortified breast milk, or breast milk 
26 replacement. Hence hygienic preparation of feed is essential due to their immature immune system 
4 
1 and lack of competing intestinal flora. Key advice from these FAO/WHO risk assessments was that 
2 PIF should be reconstituted with water >70°C, minimise any storage time by not preparing in advance 
3 and i f storage for short periods is necessary then the temperature should be <5°C. The high water 
4 temperature will drastically reduce the number of vegetative bacteria present, and minimising the 
5 storage period will reduce the multiplication of any surviving organisms. These recommendations 
6 have been well addressed by the W H O 'Guidelines for the safe preparation, storage and handling of 
7 powdered infant formula' which are available online and can be downloaded using the U R L given in 
8 the Reference section. The FAO/WHO 2004 expert committee recommended that research should be 
9 promoted to gain a better understanding of the taxonomy, ecology, virulence and other characteristics 
10 of Cronobacter. This article addresses many of these topics, using our recent findings on the genomic 
11 analysis of the organism and similarities with closely related organisms as well as issues of detection 
12 and consumer protection. 
13 
14 Taxonomy and identification schemes 
15 Taxonomy of Cronobacter 
16 Initially the organism was regarded as a pigmented variety of Enterobacter cloacae. In 1974, Brenner 
17 showed that the pigmented strains had < 50% homology with non-pigmented strains and it was 
18 suggested that they should comprise a new species (Brenner 1974). E. sakazakii was later 
19 distinguished from E. cloacae based on D N A - D N A hybridisation, pigment production, biotype 
20 assignment and antimicrobial resistance (Farmer 1980, Izard, Richar et al. 1983), the species name 
21 being derived from the Japanese bacteriologist Riichi Sakazaki. D N A - D N A hybridization values 
22 were 41% and 54% for Citrobacter freundii and E. cloacae, respectively, which were used as 
23 representatives of the Citrobacter and Enterobacter genera (Farmer 1980). The results warranted the 
24 recognition of a separate species and, as they were phenotypically closer to E. cloacae, they were kept 
25 in the Enterobacter genus. Additional phenotypic analysis led to the description of 15 E. sakazakii 
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1 biogroups, with biotype 1 being the most common (Farmer 1980). At this point, there was no clear 
2 evidence of the generic assignment of E. sakazakii to the Enterobacter genus, however. 
3 Since the 1980s, bacterial systematics has increasingly used D N A sequencing for its analysis 
4 and for determining relatedness. Analysis of both partial 16S rDNA and hsp60 gene sequencing by 
5 Iversen and Forsythe in 2004 showed that E. sakazakii isolates formed at least four distinct clusters 
6 which probably represented different closely related species (Iversen, Waddington et al. 2004). The 
7 15 different biogroups fitted into the 4 clusters, and a 16th biogroup was added in subsequent work 
8 (Iversen, Waddington et al. 2006). However, full taxonomic revision required considerable further 
9 analysis for substantiation. The Cronobacter genus was defined first in 2007 and revised in 2008 
10 (Iversen, Lehner et al. 2007, Iversen, Mullane et al. 2008). Differentiation between the newly defined 
11 Cronobacter species is primarily based on genotypic (DNA-based) analysis and is largely supported 
12 by biochemical traits (Table 1) (Iversen, Lancashire et al. 2006). With a few exceptions, the former 
13 biotypes and genomogroups correspond with the new species; as shown in Table 1. The genus 
14 Cronobacter is currently composed of C. sakazakii, C. malonaticus, C. turicensis, C. muytjensii, and 
15 C. dublinensis. Distinguishing between the two species C. sakazakii and C. malonaticus has been 
16 problematic and there are two primary reasons for this. Firstly, the use of biotype profile to designate 
17 the species was not totally robust as a few of the biotype index strains were themselves assigned the 
18 wrong species (Baldwin, Loughlin et al. 2009). Secondly, there are 7 copies of the rDNA gene in 
19 Cronobacter and intrageneric differences can lead to uncertain and inconsistent base calls. 
20 Since members of the Cronobacter genus were formerly known as the single species 
21 Enterobacter sakazakii, this name was used in publications before mid-2007. Subsequently it is 
22 uncertain which specific Cronobacter species were referred to in many pre-2007 publications. The 
23 majority of isolated strains are usually C. sakazakii, and it is probable that this has been the species of 
24 major study to date. For our part, we have tried to give cross-references for strains in our own 
25 publications to assist readers, and are available on request. Accurate bacterial taxonomy is essential 
26 for regulatory control since the detection methods must be based on a thorough understanding of the 
27 diversity of the target organism. A number of early methods were based on small numbers of poorly 
6 
1 characterised, even misidentified, strains and therefore are not necessarily reliable for their stated 
2 purpose. 
3 
4 Identification schemes 
5 The Codex Alimentarius Commission (2008) microbiological criteria are applied to PIF with the 
6 intended age < 6 months (Codex Alimentarius Commission (CAC) 2008). Hence a number of 
7 methods for the recovery of desiccation-stressed Cronobacter cells from this group of products have 
8 been developed. As the organism has only been reported at low numbers (<lcfu/g), a large volume of 
9 material needs to be tested. Subsequently the Codex Alimentarius Commission requirement is to test 
10 thirty lOg quantities, and therefore presence/absence testing of PIF is applied rather than direct 
11 enumeration. Initial Cronobacter detection methods were reminiscent of the stages for Salmonella 
12 isolation from milk powders. In brief, the steps were pre-enrichment (225ml water or BPW + 25g 
13 formula), enrichment (EE broth), plate on to V R B G agar, pick off 5 colonies to TSA and identify 
14 phenotypically any yellow pigmented colonies. It is now recognised that there are a number of 
15 limitations with this method. There is no initial selection for Cronobacter, instead any 
16 Enterobacteriaceae could be enriched in E E broth and grow on V R B G agar leading to possible 
17 overgrowth oi Cronobacter. Furthermore, not all Cronobacter strains are pigmented and so could be 
18 overlooked on TSA plates. Finally phenotype databases did not adequately cover the genus resulting 
19 in conflicting results between commercial kits. These days improved methods employ chromogenic 
20 agars, updated phenotyping databases, along with DNA-based identification and fingerprinting 
21 techniques. Cronobacter has a notable resistance to osmotic stresses, which may be linked to its 
22 ecology, and this trait has been used in the design of improved enrichment broths; modified lauryl 
23 sulphate broth containing 0.5M NaCl and Cronobacter screening broth with 10% sucrose. The use of 
24 chromogenic agar (primarily based on the a-glucosidase reaction) to differentiate Cronobacter from 
25 other Enterobacteriaceae present on the plate was a major improvement. The a-glucosidase activity 
26 as a test differentiating the then E. sakazakii from E. cloacae had been reported in the early days by 
1 Harry Muytjens (Muytjens, van der Ros-van de Repe. et al. 1984). As well as testing PIF, 
2 environmental samples are taken from the production environment as well as from ingredients 
3 (especially starches and other plant-derived material). In addition, production facilities and processes 
4 are already designed to control enteric pathogens, especially Salmonella. 
5 Commercial companies producing phenotyping kits have been updating their databases due to 
6 the taxonomic revision, for example, the former E. sakazakii Preceptrol™ strain ATCC® 51329 has 
7 been reclassified as C. muytjensii and should not be confused with C. sakazakii. The specificity of 
8 some formerly E. sakazakii DNA-based PCR probes to the diverse Cronobacter genus needs to be re-
9 evaluated, and new species-specific Cronobacter probes have been developed. 
10 16S rDNA sequences have been traditionally used to determine phylogenetic relationships 
11 between organisms including Enterobacteriaceae. However 16S rDNA sequencing is of limited use 
12 for very closely related organisms because of minor differences in the rDNA sequence. 16S rRNA 
13 gene sequencing can distinguish between the Cronobacter species as shown in Figure 1. Earlier 
14 difficulties in distinguishing between C. sakazakii and C. malonaticus was possibly due to 
15 polymorphic nucleotide sites and depended on the operator interpretation of the sequencing 
16 chromatograms for those loci. Additionally there is difficulty using biotyping to define the 
17 Cronobacter species as some strains defined as particular biotype index strains were misassigned their 
18 species. 16S rDNA sequence analysis has been applied to early strains ofE. sakazakii and other mis-
19 identifications include: 
20 1. Fatal case of neonatal sepsis infection in neonatal intensive care unit by E. sakazakii, 
21 reidentified as E. cloacae (Caubilla-Barron, Hurrell et al. 2007) 
22 2. Neonatal intensive care unit outbreak ofE. sakazakii, reidentified as E. hormaechei 
23 (Townsend, Hurrell et al. 2008) 
24 3. Quinolone-resistant E. sakazakii strain, reidentified as E. hormaechei (Poirel, Nordmann et al. 
25 2007) 
8 
1 4. Oligo-polysaccharide structure for E. sakazakii, strain re-identified as E. ludwiggi (Szafranek, 
2 Czerwicka et al. 2005) 
3 Molecular typing methods 
4 Although it is generally possible to differentiate Cronobacter species by biochemical profiling, 
5 molecular methods are increasingly used as a more rapid and reliable tool to study bacterial genomic 
6 diversity and to track sources of infection. Since the organism is ubiquitous, typing schemes are 
7 required both for epidemiological and environmental investigation. As given above, initially 15 
8 biogroups of Cronobacter were defined with biogroup 1 being the most common. These divisions, 
9 however, are not specific enough for epidemiological investigations. Instead, initial procedures used 
10 plasmid profiling, chromosomal restriction endonuclease analysis and multilocus enzyme 
11 electrophoresis (Clark, Hil l et al. 1990, Nazarowec-White, Farber 1999). This was followed by the 
12 application of Random Amplified Polymorphic D N A (RAPD) ribotyping, pulsed-field gel 
13 electrophoresis (PFGE), and M L V A (multiple-locus variable-number tandem repeat analysis) 
14 (Mullane, Ryan et al. 2008). To date, PFGE with two restriction enzymes (Xbal and Spe 1) is the most 
15 common method (Caubilla-Barron, Hurrell et al. 2007). The technique is widely employed and can 
16 be used for transnational investigations, as per PulseNet, since the gel results can be electronically 
17 analyzed (http://www.cdc.gov/pulsenet/). PFGE is considered the gold standard for genetic typing and 
18 is recommended to be used in surveillance and investigations of sources of outbreaks. 
19 Typing Cronobacter to understand its diversity has led to the development of a multilocus 
20 sequence typing (MLST) scheme which is available online (www.pubMLST.org/cronobacter) 
21 (Baldwin, Loughlin et al. 2009). The sequencing of protein coding genes is a useful, more 
22 discriminatory alternative to partial 16S rDNA sequencing (ca. 528 nucleotide length), especially as 
23 unlinked sequences from multiple protein-coding genes are used. The Cronobacter M L S T analysis is 
24 based on 7 housekeeping genes; A T P synthase beta chain (atpD), elongation factor G (fusA), 
25 glutaminyl-tRNA synthetase (glnS), glutamate synthase large subunit (gltB), D N A gyrase subunit B 
26 (gyrB), translation initiation factor IF-2 (in/B) and phosphoenolpyruvate synthase A (ppsA). The 7 
1 sequenced alleles can be concatenated together to give >3000 nucleotide for phylogenetic analysis 
2 (Fig 2). This is 6 times the length of the commonly used partial 16S rDNA sequences, and has the 
3 additional advantage of considerably greater number of variable loci. The initial publication was 
4 focussed on C. sakazakii and C. malonaticus due to the reported difficulties in distinguishing between 
5 them (Baldwin, Loughlin et al. 2009). The 7 allele phylogenetic tree (Fig 2) is comparable to the 16S 
6 tree (Fig 1). The M L S T analysis has revealed a remarkably strong clonal nature in Cronobacter. Of 
7 particular note, is that this study showed that sequence types (ST) existed which were primarily 
8 associated with infant formula (ST3), another both infant formula and clinical isolations (ST4), and 
9 another which was primarily composed of clinical isolates (ST8). The strains analysed were widely 
10 geographically, temporally and source distributed, some of which could be traced over a 50 year 
11 period. These clones may reflect different ecologies of the organism. ST8 indicates that there may be 
12 a source of Cronobacter which is not PIF associated. Therefore to focus on PIF analysis following a 
13 Cronobacter outbreak on a NICU may lead to oversight of the true source of the infection. As given 
14 above, the M L S T scheme is accessible online and has been extended to cover all Cronobacter species. 
15 The scheme will be of considerable use in the future for choosing representative Cronobacter strains 
16 when undertaking further studies. 
17 
18 Ecology and physiological aspects 
19 Plant-associated traits and sources 
20 Iversen and Forsythe hypothesized that the Cronobacter species might be of plant origin due to 
21 physiological features such as the production of a polysaccharide capsule, production of a yellow 
22 pigment and its desiccation resistance (Iversen, Forsythe 2003). These traits may enable the organism 
23 to stick to plant leaves, protect against oxygen radicals from sunlight exposure, and survive dry 
24 periods including autumn. About 80% of Cronobacter strains produce a non-diffusible, yellow 
25 pigment on Tryptone Soya Agar at 25°C. Pigment production is temperature dependent, and even 
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1 fewer strains produce it at 37°C. As given above, the organism probably colonizes plant material and 
2 the yellow carotenoid-based pigmentation may protect it from sunlight-generated oxygen radicals. 
3 A productive source of Cronobacter strains are fresh or dried herbs and spices with -30% 
4 incidence. In fact an early patent for a food thickener was material extracted from E. sakazakii 
5 isolated from Chinese tea (Harris, Oriel 1989, Scheepe-Leberkuhne, Wagner 1986). In order to 
6 provide evidence for the plant origin of Cronobacter, Schmid et al. investigated biochemical traits 
7 associated with plant microorganisms in nine strains representing the then recognised five 
8 Cronobacter species (Schmid, Iversen et al. 2009). A l l strains were able to solubilise mineral 
9 phosphate, produce indole acetic acid and produce siderophores. The strains were also able to 
10 endophytically colonise tomato and maize roots. The authors concluded that plants may be the 
11 natural habitat of Cronobacter spp. and that the rhizosphere might act as a reservoir of the bacterium. 
12 The plant association of Cronobacter may account for physiological traits such as surviving spray 
13 drying and prolonged periods in dry materials (ie. starches), and presence in ingredients that are added 
14 to PIF without additional heat treatment (FAO/WHO 2004, FAO/WHO 2006). Unlike most other 
15 Enterobacteriaceae, the organism can persist in PIF for 2 years (Caubilla-Barron, Hurrell et al. 2007). 
16 It is notable that, when the E. sakazakii species was defined, it included a strain which had been 
17 isolated from dried milk in 1960. Therefore, possibly Cronobacter has been present in dried milk 
18 products for many decades. For a fuller review of desiccation survival mechanisms please see 
19 Forsythe & Osaili (Osaili, Forsythe 2009). 
20 Cronobacter have the ability to survive osmotic stress and desiccation (Riedel, Lehner 2007, 
21 Osaili, Forsythe 2009). They are able to take up osmoprotectants including trehalose (via 
22 phosphotrasferase system, PTS), glycine, betaine, proline, spermidine, and putrescine using A B C 
23 transporters. 
24 Since the organism is probably plant associated it is not surprising that the organism can be 
25 isolated from a wide range of environments, including water, soil, herbs and spices, and a variety of 
26 processed foods and fresh produce (Friedemann 2007). The resistance to plant essential oils may be 
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1 linked to efflux pumps which contribute to the organism's resistance to osmotic pressure, and can be 
2 of use in the design of selective media. 
3 As given above, M L S T has revealed the organism may have a more complex ecology with non-
4 plant ecosystems. The bacterium has been isolated from the hospital environment and clinical 
5 samples; cerebrospinal fluid, blood, bone marrow, sputum, urine, inflamed appendix, neonatal enteral 
6 feeding tubes and conjunctivae. Asymptomatic human carriage (intestines and throat) have also been 
7 reported. The bacterium has been isolated from factories producing milk powder, household vacuum 
8 cleaning bags and also from household utensils used for the reconstitution of PIF (Muytjens, Roelofs-
9 Willemse et al. 1988, Bar-Oz, Preminger et al. 2001, Block, Peleg et al. 2002, Kandhai, Reij et al. 
10 2004). 
11 
12 Powdered infant formula, follow up formula and weaning foods 
13 Cronobacter was first associated with contaminated PIF by Muytjens et al. in 1988 (Muytjens, 
14 Roelofs-Willemse et al. 1988) when it was isolated from prepared formula and reconstitution 
15 equipment. They reported 52.2% (n=141) of PIF samples from 35 countries contained 
16 Enterobacteriaceae, with 14% containing Cronobacter spp. (Muytjens, Roelofs-Willemse et al. 
17 1988). A more recent international survey for Cronobacter and related organisms in PIF, follow up 
18 formula and infant foods was conducted by 8 laboratories in 7 countries in response to the call for 
19 data in preparation for the FAO/WHO 2008 risk assessment. In total, 290 products were analysed 
20 using a standardised procedure. Cronobacter was isolated from 3 % (n=91) follow up formulae and 
21 12 % (n=199) infant foods and drinks (Chap, Jackson et al. 2009). The few reported quantitative 
22 studies do not show any samples with Cronobacter at levels >1 cell/g PIF. In fact <1 cell in lOOg 
23 may be more representative and explains why large sample volumes (30 x lOg) are required for 
24 testing. Hence, the need to consider opportunities for extrinsic bacterial contamination and 
25 multiplication during formula preparation. Due to the ubiquitous presence of Cronobacter and its 
12 
1 resistance to dry conditions, contamination of food products including PIF is difficult to avoid. 
2 Cronobacter does posses the gene encoding the universal stress protein UspA, which is also found in 
3 other closely related Enterobacteriaceae (E. coli, Enterobacter cloacae, Citrobacter koseri, and 
4 Pantoea spp.). In E. coli the protein is induced following both heat and osmotic shock. Hence it may 
5 be important in the survival of Cronobacter during manufacturing processes and the cross-induction 
6 of other protection mechanisms. 
7 Capsule and biofilm formation 
8 Cronobacter do not have the pgaABCD locus which in E. coli promotes its binding to abiotic surfaces 
9 and encodes for (3-1,6-jV-acetyl-D-glucosamine. Instead, the organism often produces a 
10 heteropolysaccharide capsule composed of glucuronic acid, D-glucose, D-galactose, D-fucose and D-
11 mannose. Strains from NICU outbreaks produce so much capsular material that on milk agar plates 
12 the colonies drip onto the lid of inverted Petri dishes (Caubilla-Barron, Hurrell et al. 2007). This 
13 material has been patented for use as a thickening agent in foods (Scheepe-Leberkuhne, Wagner 1986, 
14 Harris, Oriel 1989). The capsular material, induced under nitrogen-limited conditions, could facilitate 
15 the organism's attachment to plant surfaces. Combined with a tolerance to desiccation, this gives the 
16 organism an armoury to colonize plant material and maybe survive harsh, environmental conditions. 
17 These traits may also contribute to the organism's presence in starches used in the manufacture of 
18 infant formula and persistence during the manufacturing process. The organism attaches to surfaces, 
19 forming biofilms that are resistant to cleaning and disinfectant agents, and the organism has been 
20 isolated as part of the mixed flora biofilm in enteral feeding tubes of neonates not fed PIF (Hurrell, 
21 Kucerova et al. 2009b). 
22 Cronobacter is able to adhere to silicon, latex and polycarbonate and to a lesser extent to 
23 stainless steel (Iversen, Forsythe 2003). Furthermore, Cronobacter has been reported to attach and 
24 form biofilm on glass and polyvinyl chloride (Lehner, Riedel et al. 2005). A l l of these materials are 
25 commonly used for infant-feeding and food preparation equipment and, i f contaminated, may increase 
26 the risk of infection. Beuchat et al. reported that the ability of Cronobacter to form a biofilm is 
13 
1 affected by the composition of the media (Beuchat, Kim et al. 2009), and that it is enhanced by infant 
2 formula components. The infant formula composition can also increase Cronobacter resistance to 
3 disinfectants, as shown by Beuchat et al. who examined the effect of thirteen disinfectants commonly 
4 used in infant formula preparation areas (Kim, Ryu et al. 2007). Populations of Cronobacter cells 
5 suspended in water (ca. 7 log CFU/ml) decreased to undetectable levels (< 0.3 log CFU/ml) within 1-
6 5 min of treatment with disinfectants, whereas numbers of cells in reconstituted PIF diminished by 
7 only 0.02-3.69 log CFU/ml after treatment for 10 min. Furthermore, cells attached to stainless steel 
8 were less resistant to disinfectants. It is clear that the ability of Cronobacter to attach to surfaces, 
9 form biofilms, and resist dry stress conditions contribute to the risk of Cronobacter ingestion. 
10 Moreover, the composition of PIF has a strong protective effect on the survival of Cronobacter. 
11 Cronobacter appear to have the carbon storage regulatory (Csr) system as evident by the 
12 presence of Csr A in both C. sakazakii and C. turicensis genomes. Although its regulatory role in 
13 Cronobacter is unknown at present, its role in E. coli has been well established. CsrA is an R N A -
14 binding protein that binds to the untranslated leader sequences of target mRNAs and alters their 
15 translation and stability. It represses stationary phase processes, including glycogen synthesis and 
16 catabolism, gluconeogenesis, and biofilm formation. It also activates glycolysis, motility, and biofilm 
17 dispersal. Repression of biofilm formation by CsrA involves the synthesis and catabolism of 
18 intracellular glycogen. Therefore biofilm formation in Cronobacter is probably linked to central 
19 carbon metabolism. 
20 Finally, high levels of heat-stable lipopolysaccharide (endotoxin) in infant formula may 
21 enhance the translocation of Cronobacter across both the intestines and the blood-brain barrier, and 
22 therefore increase the risk of bacteraemia in neonates (Townsend, Caubilla Barron et al. 2007). Levels 
23 of endotoxin vary 500-fold in PIF. The chemical structure of oligopolysaccharide from three 
24 Cronobacter species; C. sakazakii BAA-894, 767, C. malonaticus and C. muytjensii have been 
25 derived (Czerwicka, Forsythe et al. 2010, MacLean, Pagotto et al. 2009a, MacLean, Pagotto et al. 
26 2009b, MacLean, Vinogradov et al. 2009). The material is branched in C. sakazakii and linear in C. 
14 
1 muytjensii. Whether the surface structure is important in virulence remains to be determined but may 
2 serve as a basis for serotyping and other characterisation methods. 
3 Temperature response 
4 Cronobacter can grow over a wide temperature range. Due to interest in the organism and infant 
5 infections, growth and death rates have been determined in reconstituted infant formula. At room 
6 temperature (21°C), Cronobacter had a doubling time of 40-94 minutes. The lowest permissible 
7 growth temperature is near refrigeration (~5°C) and therefore the organism may grow following 
8 prolonged storage or poor temperature control. The maximum growth temperature (44-47°C) is strain 
9 dependent, and the C. sakazakii type strain (ATCC 29544T) is reported not to grow above 42°C 
10 (Nazarowec-White & Farber 1997) the temperature used for the ISO/TS 22964 isolation method . 
11 Recent studies show that C. turicensis grows at <5°C which is lower than other Cronobacter species 
12 and has a lower maximum temperature (Caubilla-Barron, Kucerova et al. 2009). 
13 Decimal reduction times and z-values vary considerably between strains, i.e. D5 5 2-49 
14 minutes, z-values 2-14°C (Caubilla-Barron, Kucerova et al. 2009). Early studies inferred the organism 
15 was very thermotolerant. However, subsequent work clarified that the organism was less 
16 thermotolerant than L . monocytogenes (Nazarowec-White and Farber 1999). Nevertheless, the 
17 organism can survive spray drying albeit with a considerable reduction in viability, and the surviving 
18 cells may be severely damaged (Caubilla-Barron, Kucerova et al. 2009). The organism's tolerance to 
19 drying has been well noted, and it can survive for two years desiccated in infant formula and then 
20 rapidly grow on reconstitution (Barron, Forsythe 2007). 
21 The first and second FAO/WHO meetings (2004 and 2006) reviewed the organisms 
22 associated with neonatal infections, those found in PIF, and also those that had been 
23 epidemiologically linked (FAO/WHO 2006, FAO/WHO 2004). Subsequently, Salmonella and 
24 Cronobacter were designated Category A (Clear evidence of causality), and other named 
25 Enterobacteriaceae and Acinetobacter were in Category B (Causality plausible, but not yet 
15 
1 demonstrated). In order to reduce the number of intrinsic bacteria and limit bacterial growth, the 
2 FAO/WHO (2004 and 2006) expert committees proposed that PIF be reconstituted at temperatures no 
3 cooler than 70°C, and that it is used immediately rather than stored (FAO/WHO 2006, FAO/WHO 
4 2008). As stated earlier, a common feature in a number of outbreaks has been a lack of adequate 
5 hygienic preparation and temperature control of the reconstituted infant formula. A second outcome 
6 from the FAO/WHO meetings was the production of an online risk model; 
7 http://www.mramodels.org/ESAK/default.aspx. The model allows the user to compare the level of 
8 risk between different levels of contamination and reconstitution practices. The model was based on 
9 growth and death kinetic data for a limited number of Cronobacter strains. We recently extended the 
10 Risk Model to cover all organisms in Categories A & B; Cronobacter species, Salmonella, other 
11 named Enterobacteriaceae and Acinetobacter spp. It can be accessed from the U K FSA web site at 
12 http://www.foodbase.org.uk/results.php?f_category_id=&f_report_id=395. The data was generated 
13 using casein- and whey-based formulas as the type of formula affects bacterial lag times, growth and 
14 death rates. 
15 As referred to above, the W H O guidelines for hygienic preparation of PIF are aimed at reducing 
16 the number of bacteria in the reconstituted product by using hot water and limiting the time available 
17 for any survivors to multiply. However a wider perspective is that neonates are frequently feed via 
18 enteral feeding tubes. These tubes are in place for prolonged periods (even several days) to reduce 
19 distress to the neonate by the gagging reaction. However Cronobacter, and other opportunistic 
20 pathogens can attach and colonise these tubes which are at 37°C, and at regular intervals receive fresh 
21 feed (Hurrell, Kucerova et al. 2009a, Hurrell, Kucerova et al. 2009b). This scenario is applicable to all 
22 neonates with nasogastric tubes, and not only those on reconstituted PIF. In fact Cronobacter and 
23 other Enterobacteriaceae have been isolated from such tubes in intensive care units from neonates 
24 receiving breast milk and various other feeding regimes at levels up to 107 cfu per tube (Hurrell, 
25 Kucerova et al. 2009a, Hurrell, Kucerova et al. 2009b). Therefore hygienic practices and avoidance of 
26 temperature abuse are vitally important regardless of the type of feed. 
27 
16 
i Cronobacter virulence 
2 Adult and neonate infections 
3 It may be a surprise to some readers but Cronobacter infections are not unique to neonates. In fact 
4 they occur in all age groups, with the greater incidence in the more immuno-compromised very young 
5 and elderly. A major difference between the age groups is the severity of infection in neonates. 
6 Infections caused by Cronobacter in adults comprise a wide range of symptoms from conjunctivitis, 
7 biliary sepsis, urosepsis and appendicitis to wound infection and pneumonia. Infections in neonates 
8 include infant meningitis and necrotizing enterocolitis (Gurtler, Kornacki et al. 2005). Adult patients 
9 at increased risk include those previously treated with antibiotics, immuno-compromised and elderly 
10 patients, those with medical implants or with acute, chronic, or serious illnesses (Sanders and Sanders 
11 1997, Pitout, Moland et al. 1997). 
12 According to the FAO/WHO (2008) around the world there have been 120 documented 
13 Cronobacter cases and at least 27 deaths (FAO/WHO 2008). This is undoubtedly an underestimate. 
14 In the USA, the reported Cronobacter infection incidence rate is 1 per 100 000 infants. This incidence 
15 rate increases to 9.4 per 100 000 in infants of very low birth weight, i.e. <1.5 kg. Symptoms in 
16 neonates include necrotising enterocolitis (NEC), septicaemia and meningitis. The former is non-
17 invasive (and is multifactorial), whereas in septicaemia and meningitis the organism has attached and 
18 invaded presumably through the intestinal epithelial layer. NEC is a common gastrointestinal illness 
19 in neonates and can be caused by a variety of bacterial pathogens. It is characterized by ischaemia, 
20 bacterial colonisation of the intestinal tract, and increased levels of proteins in the gastrointestinal 
21 lumen. The incidence of NEC is 2-5% of premature infants and 13% in those weighing <1.5kg at 
22 birth. It is 10 times more common in infants fed formula compared with those fed breast milk (Lucas, 
23 Cole 1990). Necrotizing enterocolitis has a high mortality rate; 15-25% of cases (Henry, Moss 2009). 
24 Cronobacter has been implicated as a causative agent of necrotizing enterocolitis (NEC), but 
25 its role in the pathogenesis of the disease is somewhat unclear. There are reports of Cronobacter 
17 
1 isolation from babies who developed NEC (van Acker, de Smet et al. 2001, Caubilla-Barron, Hurrell 
2 et al. 2007). This suggests that there is an association between Cronobacter occurrence and NEC, 
3 although until recently, the organism has not been conclusively proven to cause the disease. 
4 Infant meningitis can be caused by a variety of bacterial pathogens, including Cronobacter and 
5 its close relatives Enterobacter cloacae and Citrobacter koseri. Cronobacter-related meningitis is 
6 characterized by a mortality rate of 40-80 % and generally a very poor clinical outcome. The 
7 bacterium causes cystic changes, abscesses, fluid collection, brain infarctions, hydrocephalus, necrosis 
8 of brain tissue and liquefaction of white cerebral matter. Patients surviving Cronobacter-related 
9 meningitis often suffer from severe neurological sequelae, such as hydrocephalus, quadriplegia and 
10 retarded neural development (Lai 2001). The infection usually arises between the fourth and fifth day 
11 after birth and it can be fatal within hours to days following the first clinical signs (Muytjens, Zanen et 
12 al. 1983). Compared with patients suffering from Cronobacter-mduced enterocolitis, infants in whom 
13 meningitis developed tend to have normal gestational age and birth weight (Bowen and Braden 2006). 
14 Sources of infection 
15 While the source of contamination in Cronobacter-related outbreaks has not always been confirmed, 
16 breast milk substitutes (one group of PIF products) have been epidemiologically or microbiologically 
17 established as the source of infection in a number of cases (Muytjens, Zanen et al. 1983, Biering, 
18 Karlsson et al. 1989, Simmons, Gelfand et al. 1989, Clark, Hil l et al. 1990, Muytjens and Kollee 
19 1990, van Acker, de Smet et al. 2001, Weir 2002, Iversen and Forsythe 2003). A strong link between 
20 the presence of Cronobacter in formula feeding and an outbreak of Cronobacter infection was 
21 established by Center for Disease Control and Prevention in 2002 following the outbreak in a neonatal 
22 intensive care unit (NICU) in Tennessee in 2001. In this outbreak, one neonate died from 
23 Cronobacter-mduced meningitis and further 10 cases of Cronobacter colonisation were found on the 
24 same unit. Later investigation revealed that the formula fed to the infant in Tennessee was in fact a 
25 formula that was not intended for neonates. 
18 
1 Infections have been directly linked to reconstituted PIF which may have been contaminated 
2 intrinsically or during preparation and administration. A common feature in some of these outbreaks 
3 is the opportunity for temperature abuse of the prepared feed, which would permit bacterial growth. 
4 In reported outbreaks in France and USA, the neonates were fed using perfusion devices whereby the 
5 reconstituted PIF is slowly pumped at ambient temperature into the neonate through an enteral 
6 feeding tube (Himelright, Harris et al. 2002, Caubilla-Barron, Hurrell et al. 2007). Using this 
7 procedure there is the possibility of bacterial multiplication in the syringe leading to the ingestion of 
8 large numbers of Cronobacter by the neonate. The neonate has an immature immune system and a 
9 low intestinal microflora density. Consequently, i f a large number of Cronobacter cells were ingested 
10 they would not be outcompeted by the resident intestinal flora. Following invasion of the intestinal 
11 cells, the lack of a developed immune system could make the neonate more prone to systemic 
12 infection. No infectious dose has been determined for neonates. Animal studies by Pagotto, 
13 Nazarowec-White et al. (2003) and Richardson et al. (2009) have used large numbers of Cronobacter 
14 cells (~108) for infection studies. Whether this number is reflective of that necessary for neonates is 
15 uncertain, but it does contrast with the number of cells reported in contaminated PIF (<1 cfu/g), and 
16 may therefore indicate the role of temperature abuse in enabling bacterial multiplication. 
17 It is pertinent to note that the bacterium is isolated from the tracheae and has been recovered 
18 from the feeding tubes of neonates fed breast milk and ready-to-feed formula, not infant formula 
19 (Hurrell, Kucerova et al. 2009b). Therefore wider sources of the organism during an outbreak need to 
20 be investigated, not just the use of PIF. Infants can be colonized by more than one strain of 
21 Cronobacter, and therefore multiple isolates need to be characterized by PFGE in epidemiological 
22 investigations (Caubilla-Barron, Hurrell et al. 2007). 
23 Bowen and Bradden have reported that there are a number of neonatal cases which have no 
24 links with the ingestion of infant formula (Bowen and Braden 2006). Therefore in epidemiological 
25 investigations multiple sources should be sampled. Breast milk can contain the bacterium, and the C. 
26 malonaticus type strain ( L M G 23826T) was isolated from a breast abscess. In some countries breast 
27 milk from mothers with mastitis is still fed to the neonate. The organism has also been isolated from 
19 
1 hospital air, human intestines and throats. So control of microbiological content of PIF will not 
2 necessarily totally remove the risk of neonate infection by this bacterium. 
3 Virulence factors 
4 A l l Cronobacter species have been associated with clinical infections in infants or adults and are 
5 considered potentially pathogenic. To date, isolates from infected neonates have been limited to only 
6 three species; C. sakazakii, C. malonaticus and C. turicensis (Kucerova et al. 2010). These species 
7 can invade human intestinal cells, replicate in macrophages and invade the blood-brain barrier. It is 
8 known that Cronobacter strains and species vary in their virulence (Caubilla-Barron et al. 2007). In 
9 vitro studies have shown that bacterial attachment and invasion of mammalian intestinal cells, 
10 macrophage survival and serum resistance is comparable with E. cloacae and Cit. freundii, but less 
11 than that for Salmonella Typhimurium (Townsend, Hurrell et al. 2007). Strains from C. sakazakii and 
12 C. malonaticus showed higher invasion of Caco-2 (human cell line) than other Cronobacter species. 
13 Similarity C. sakazakii and C. malonaticus survive and replicate in macrophages inside phagosomes, 
14 whereas C. muytjensii die, and C. dublinensis is serum sensitive. Virulence also varies within the C. 
15 sakazakii species. This was determined from epidemiological studies of an NICU outbreak in France 
16 where the clinical outcome of three C. sakazakii pulsetypes varied with only one pulsetype causing 
17 the three deaths (Caubilla-Barron, Hurrell et al. 2007). Additionally this variation in virulence is 
18 supported by mammalian tissue culture studies (Pagotto, Nazarowec-White et al. 2003, Townsend, 
19 Hurrell et al. 2007, Townsend, Hurrell et al. 2008) and appears to have been confirmed by recent 
20 M L S T studies (Baldwin, Loughlin et al. 2009). OmpA is produced by Cronobacter and has been used 
21 as an identification trait. This protein has been extensively studied in E. coli K l as contributes to the 
22 organism's serum resistance, adhesion to host cells and invasion of brain microvascular endothelial 
23 cells. It is logical to predict that it also has a role in Cronobacter penetrating the blood-brain barrier. 
24 However the mechanism leading to the destruction of the brain cells is unknown and could, in part, be 
25 a host response. Cronobacter may invade the tissues using pathogenic secretory factors (elastases, 
26 glycopeptides, endotoxins, collagenases and proteases) which increase the permeability of the blood-
20 
1 brain barrier and allow the organism to gain access to the nutrient-rich cerebral matter (Iversen and 
2 Forsythe 2003). Only a limited number of animal studies have been undertaken on C. sakazakii, 
3 principally by Pagotto and colleagues (Pagotto, Nazarowec-White et al. 2003) and Richardson and 
4 colleagues (Richardson, Lambert et al. 2009) but these have confirmed the variation within the 
5 species. 
6 In Cronobacter meningitis there is gross destruction of the brain, leading sadly to either death 
7 (40-80% of cases) or severe neurological damage. This pathogenesis is different to that caused by 
8 both Neisseria meningitidis and neonatal meningitic E. coli. Some reports suggest a similarity 
9 between the tropism of Cronobacter and the closely related organism Cit. koseri for invasion and 
10 infection of the central nervous system (Willis and Robinson 1988, Burdette and Santos 2000). Kline 
11 noted that brain abscesses caused by Cronobacter and Cit. koseri were morphologically similar and 
12 may be due to similar virulence mechanisms (Kline 1988). Although the production of an enterotoxin 
13 by some Cronobacter strains described by Pagotto et al. (Pagotto, Nazarowec-White et al. 2003) is 
14 widely acknowledged, the genes encoding the putative toxin have yet to be identified. The C. 
15 sakazakii type strain A T C C 29544T showed no enterotoxin production in their study, which confirms 
16 that there are considerable differences in virulence among Cronobacter strains and that some strains 
17 may be non-pathogenic. Kothary et al. characterized a zinc metalloprotease, zpx, which was unique 
18 to 135 Cronobacter strains tested, which could allow the bacterium to penetrate the blood-brain 
19 barrier and cause meningitis (Kothary, McCardell et al. 2007). The protein is found in all 
20 Cronobacter species (Kucerova, Clifton et al. 2010), although there is some sequence variation 
21 (Kothary, McCardell et al. 2007). Although C. muytjensii has not been associated with neonatal 
22 infections, one strain (ATCC 51329T, source unknown) has been used in animal studies to 
23 demonstrate its potential to infect neonates (Mittal, Wang et al. 2009). 
24 Townsend et al. showed that Cronobacter can attach to intestinal Caco2 cells and survive in 
25 macrophages, but the invasion mechanism remains unknown (Townsend, Hurrell et al. 2007). 
26 (Kucerova, Clifton et al. 2010) referred to a prophage encoding a protein homologous to the Eae 
27 adhesion protein. This however only encodes for a small portion of the protein and probably has not 
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1 physiological relevance. Kim and Loessner suggested that the invasion of Cronobacter to Caco2 
2 cells may be receptor-mediated, as the bacterial invasion showed characteristics of saturation kinetics 
3 (Kim and Loessner 2008). The authors also concluded that bacterial de novo protein synthesis was 
4 required for invasion. In the same study, pretreatment of Caco2 cells with an actin polymerization 
5 inhibitor resulted in decreased invasiveness of Listeria monocytogenes and Salmonella Typhimurium, 
6 but enhanced the invasiveness of Cronobacter. The authors hypothesized that this enhancement was 
7 due to the disruption of tight junction, a membrane-associated structure that acts as a barrier against 
8 the molecular exchange between epithelial cells. This was confirmed when the disruption of the tight 
9 junction by EGTA significantly increased the invasive properties of Cronobacter. They also 
10 speculated that frequent lipopolysaccharide contamination of PIF that is known to disrupt tight 
11 junctions might contribute to the invasiveness of Cronobacter (Kim and Loessner 2008). 
12 Townsend et al. studied seven C. sakazakii strains associated with the largest reported NICU 
13 outbreak with the most reported deaths to date. A l l strains were able to attach and invade intestinal 
14 cells Caco2 more than E coli K12 and Salmonella Enteritidis (Townsend, Hurrell et al. 2008). Two 
15 strains (767 and 701), both associated with fatal cases of meningitis and NEC, showed the highest 
16 invasion rates. These two strains were also able to replicate within macrophages, while all other 
17 strains survived inside macrophages for at least 48 h (Townsend, Hurrell et al. 2008). 
18 Antibiotic susceptibility 
19 When an infection by Cronobacter occurs, it is essential to provide rapid antibiotic treatment. 
20 Although the bacterium tends to be more sensitive to most antibiotics compared to other 
21 Enterobacteriaceae, its increasing resistance to some antibiotics has proven problematic. 
22 Cronobacter related infections have been traditionally treated with ampicillin combined with 
23 gentamycin or chloramphenicol (Lai 2001). Unfortunately, the organism has developed resistance to 
24 ampicillin (Muytjens, Zanen et al. 1983, Lai 2001) and gentamicin use is limited as it fails to reach 
25 sufficient concentrations in the cerebral spinal fluid (Iversen and Forsythe 2003). In 1980, all strains 
26 tested by Farmer were susceptible to ampicillin (Farmer 1980). In 2001, Lai described five cases of 
22 
1 Cronobacter infection in which one or more of the isolates were resistant to ampicillin and most 
2 cephalosporins of 1st and 2nd generation (Lai 2001). Kim et al. reported frequent resistance of 
3 Cronobacter food isolates to ampicillin and cephalotin (Kim, Jang et al. 2008). For this reason, the 
4 shift to carbapenems or 3rd generation cephalosporins with an aminoglycoside or trimethoprim with 
5 sulfamethoxazole was proposed. This treatment improved the outcome of Cronobacter meningitis, 
6 but may also have caused the increase in resistance to these antimicrobials (Lai 2001). 
7 Initial reports concerning the ability of Cronobacter to produce (3-lactamases gave conflicting 
8 results. The presence of B-lactamases in Cronobacter was reported in a study by Pitout et al. when all 
9 tested strains were positive for Bush group 1 B-lactamase (cephalosporinase) (Pitout, Moland et al. 
10 1997). In 2001, Lai reported increasing P-lactamase production among Cronobacter strains (Lai 
11 2001). Similarly, Block and colleagues reported that all Cronobacter isolates tested were P-lactamase 
12 positive (Block, Peleg et al. 2002). However, Stock and Wiedemann did not find any evidence of P-
13 lactam production in the 35 Cronobacter strains tested (Stock and Wiedemann 2002). The 
14 discrepancy in the results might be due to the different selection of strains, the limited number of 
15 strains used, as well as differences in the experimental protocol. Also, some Enterobacter strains 
16 express P-lactamases at very low levels, which might have not been detectable by the methods used. 
17 Genome studies 
18 Genome description of C. sakazakii and C. turicensis 
19 The genome of the C. sakazakii strain (BAA-894) from the formula associated with the neonate 
20 infection in Tennessee (Himelright, Harris et al. 2002) has been sequenced and published (Kucerova, 
21 Clifton et al. 2010). This can be compared with the unpublished genome sequence of C. turicensis 
22 strain z3032 which was also associated with a neonatal infection and has been sequenced by the 
23 Technische Universitaet Muenchen, Germany. The sequences are available online (RefSeq numbers 
24 NC_009778 and NC_013282 respectively). Additionally, the proteome of the same C. turicensis 
25 strain has been published, which will considerably assists in our understanding the organism 
23 
1 (Carranza, Hartmann et al. 2009). The genome of C. sakazakii comprises a 4.4 Mbp chromosome and 
2 two plasmids (31 and 131 kbp). The C. turicensis z3032 genome is similar; chromosomal size 4.4 
3 Mbp, three plasmids (20, 50 and 140 kbp). The %GC of both Cronobacter strains is 57-58%, which 
4 is greater than that of the closely related organism Enterobacter cloacae. Both Cronobacter strains 
5 have a large plasmid (131 and 140 kbp) with the same %GC ratio as the chromosome and a large 
6 number of genes, as well as smaller plasmids with a lower (51%) GC content. Despite the apparent 
7 similarities between the plasmids with respect to sizes and %GC content, caution should be exercised 
8 as plasmids do vary between species and in early work plasmid profiling was used for 
9 epidemiological purposes (Clark, Hil l et al. 1990). Three putative prophage genomes and three 
10 putative prophage fragments were identified in C. sakazakii BAA-894. These have been described in 
11 detail already (Kucerova, Clifton et al. 2010). C. turicensis z3032 genome also contains at least three 
12 putative prophages as identified by Prophinder (Lima-Mendez, Van Helden et al. 2008). The 
13 presence of these phage regions is important as prophages can play an important role in evolution of 
14 bacteria by introducing novel genes of different biological functions and contribute to their virulence 
15 properties. 
16 
17 Comparative genomic hybridisation studies of the Cronobacter species 
18 Of the 4,382 annotated genes, -55% (2404) were present in all C. sakazakii strains, and 43% (1899) 
19 were present in all Cronobacter species (Kucerova, Clifton et al. 2010). Note that when genes defined 
20 as intermediate are included, the core gene set for C. sakazakii species constitutes 80.9% (3547) genes 
21 and core gene for Cronobacter genus includes 75.3% (3301) genes. The vast majority of these shared 
22 genes are predicted to encode cellular essential functions such as energy metabolism, biosynthesis, 
23 DNA, R N A and protein synthesis, cell division and membrane transport. The proportion of genes 
24 absent from test strains compared with C. sakazakii BAA-894 ranged from 10.3% (453) in C. 
25 sakazakii strain 20 to 17.1% (751) in C. muytjensii (Kucerova, Clifton et al. 2010). 
24 
1 Whole-genome clustering based on the comparative genomic hybridization data by Kucerova 
2 and colleagues revealed that Cronobacter strains formed two distinct phylogenetic clusters. A l l C. 
3 sakazakii strains formed one cluster, whereas C. malonaticus, C. turicensis, C. dublinensis and C. 
4 malonaticus formed a second, separate cluster. Within C. sakazakii, strains 701 and 767 were the most 
5 closely related and clustered together with strain 20. Previously, strains 701 and 767 were shown to 
6 belong to the same pulse field gel electrophoresis restriction digestion type (Caubilla-Barron, Hurrell 
7 et al. 2007). Although the clinical details of the source of C. sakazakii strain 20 are unknown, the 
8 strain belongs to M L S T sequence type 4 (as do 701 and 767). This is a stable clone of C. sakazakii 
9 isolated from both PIF and clinical sources (Baldwin, Loughlin et al. 2009). C. sakazakii strain A T C C 
10 29544T (species type strain) formed a separate branch within the C. sakazakii cluster. The remaining 
11 Cronobacter species formed sub-clusters: C. malonaticus clustered with C. turicensis and C. 
12 dublinensis grouped with C. muytjensii. 
13 The differences in gene content that contributed to the separation of Cronobacter species into 
14 different branches were further analysed. Thirteen gene clusters that were present in all C. sakazakii 
15 strains but absent in some or all other Cronobacter species were identified and denoted SRI-SRI 3. 
16 The presence of these regions in different Cronobacter species is summarised in Table 2. SR 1 
17 (ESA_00257 - ESA_00258) encodes a putative toxin/antitoxin pair RelE/RelB, which, i f encoded on 
18 plasmids, may help to maintain a plasmid in a bacterial population. When encoded on a chromosome, 
19 however, the toxin/antitoxin system probably represents selfish DNA. SR2 (ESA_01116 -
20 ESA_01119) is a cluster of genes encoding a complete ABC-type multidrug efflux system. 
21 ESA_01116 encodes a multidrug efflux pump, ESA_01117 encodes an outer membrane efflux protein 
22 from a family including TolC, ESA01118 is the permease component of the ABC-type system and 
23 ESA_01119 encodes the ATPase component of the efflux system. SR3 (ESA_01448 - ESA_01450) 
24 encodes three proteins from the family of fatty acid desaturases. Members of this family are involved 
25 in cholesterol biosynthesis and biosynthesis of a plant cuticular wax, but may be implicated in other 
26 biosynthetic pathways. SR4 (ESA_02125 - ESA_02129) encodes a diverse group of proteins where 
27 no common assignment to a pathway or mechanism could be found; it includes acetyltransferases, a 
25 
1 transcriptional regulator from the lysR family and a putative esterase/lipase. ESA_02129 encodes a 
2 serine protease inhibitor ecotin; ecotins from species that come into contact with the mammalian 
3 immune system like E.coli, Y. pestis and P. aeruginosa have been shown to protect bacteria against 
4 the effects of neutrophil elastase (Eggers, Murray et al. 2004). SR5 (ESA_02538 - ESA_02542) is a 
5 cluster of fimbrial genes (Described in 5.3). The genes in SR6 (ESA_02544 - ESA_02547) are 
6 involved in the metabolism of beta-glucosides. ESA_02544 is a transcriptional antiterminator from 
7 the BglG family, which is involved in positive control of the utilization of different sugars by 
8 transcription antitermination (Bardowski, Ehrlich et al. 1994). ESA_02545 encodes a kinase than 
9 converts beta-glucosides to 6-phospho-beta-glucosides and ESA_02546 encodes a 6-phospho-beta-
10 glucosidase (EC 3.2.1.86) specific to arbutin-6 phosphate and salicilin-6-phosphate. ESA_02547 also 
11 encodes 6-phospho-beta-glucosidase (EC 3.2.1.86) which may have the same or similar function as 
12 ESA_02546. SR7 (ESA_02549 - ESA_02553) may encode a complete A B C multidrug transport 
13 system. SR8 (ESA_02616 - ESA_02618) contains genes related to mannose metabolism. ESA_02616 
14 encodes an alpha-mannosidase, ESA_02617 is a gene taking part in the mannosyl-D-glycerate uptake 
15 via the phosphotransferase system and ESA_02618 encodes a mannosyl-D-glycerate 
16 transport/metabolism system repressor. SR9 (ESA_02795 - ESA_02799) is a fimbrial cluster 
17 (described in 5.3). Genes in SR10 (ESA_03301 - ESA_03305) encode proteins involved in the 
18 metabolism of fructose and mannose via the PTS and a putative porin KdgM. ESA_03301 encodes an 
19 isomerizing glucosamine-fructose-6-phosphate aminotransferase. ESA_03302, located on the opposite 
20 strand to the rest of the genes in this cluster, encodes an oligogalacturonate-specific porin protein 
21 (KdgM). ESA_03303 encodes a fructose-specific II component of the PTS system FruA, which 
22 converts fructose to fructose-1-phosphate. ESA_03304 encodes an alpha-mannosidase involved in 
23 mannose degradation. ESA_03305 encodes a phosphomannose isomerase, which converts D-
24 mannose to beta-D-glucose-6-phosphate. SRI 1 (ESA_03609 - ESA_03613) is a cluster of genes also 
25 putatively involved in metabolism of mannose and other sugars. ESA_03609 encodes a putative beta-
26 galactosidase. Genes ESA_03610 and ESA_03612 encode genes involved in the TV-acetylneuraminate 
27 and jV-acetylmannosamine degradation pathway. ESA_03610 encodes a N-acetylmannosamine 
28 kinase and ESA_03611 encodes a N-acetylneuraminate lyase. Gene ESA_03612 encodes a 
26 
1 transcriptional regulator from the GntR family. SR 12 (ESA_04067 - ESA_04073) is a cluster of 
2 fimbrial genes (described in 5.3). SR13 (ESA_04101 - ESA_04106) encodes genes that may be 
3 involved in the O P S biogenesis. ESA_04102 encodes a glycosyltransferase involved in cell wall 
4 biogenesis, ESA_04103 encodes a putative O-antigen ligase or a related enzyme. Genes ESA_04104 
5 and ESA_04105 encode glycosyltransferases and ESA_04105 encodes a putative lipopolysaccharide 
6 heptosyltransferase III. This cluster is a part of a larger cluster of genes involved in LPS biogenesis, 
7 however, it is not related to the O-antigen cluster defined by Mullane and colleagues (Mullane, 
8 O'Gaora et al. 2008). The genes from this cluster were absent in C. malonaticus, but present or 
9 intermediate in all other Cronobacter species, but the putative O-antigen ligase (ESA_04103) was 
10 absent from all Cronobacter species except C. sakazakii. 
11 Variations in virulence traits as revealed by C G H are covered in more detail in the following section. 
12 The chemical structure of oligo-polysaccharide (O-antigen) in three Cronobacter species has 
13 been determined and shown to be compositionally and structurally different. It is therefore 
14 predictable that the biosynthetic pathways will vary across the genus and this has been confirmed by 
15 CGH. The gene cluster corresponding to the O-antigen cluster described by (Mullane, O'Gaora et al. 
16 2008) (ESA_01177-ESA_01189) was examined. The genetic architecture of the O-antigen cluster in 
17 the sequenced C. sakazakii BAA-894 corresponds to the serotype 0:1 as defined by Mullane and 
18 colleagues. According to our C G H data, two of the genes in this region, galF (ESA_01177) and rfbB 
19 (ESA_01178) are conserved among all Cronobacter strains tested except C. sakazakii 696, whereas 
20 the rest of the genes from the O-antigen locus are highly divergent; its genes were not sufficiently 
21 similar to be detected by microarray hybridization in any other Cronobacter strains. This correlates 
22 with the findings of Mullane and colleagues, who showed that both serotypes 0:1 and 0:2 had the 
23 two genes galF and rfbB in common, whereas the rest of the gene cluster content differed between the 
24 two serotypes. 
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1 Virulence traits and survival mechanisms 
2 Since Cronobacter is associated with neonates and infants, the availability of iron in milk or formula 
3 could be an important virulence trait. A list of known iron assimilation mechanisms was compiled 
4 and their presence in different Cronobacter species was evaluated based on the available CGH data 
5 (Kucerova, Clifton et al. 2010). A l l Cronobacter strains examined by C G H possess complete operons 
6 for enterobactin synthesis (entABCDEFS) and enterobactin receptor and transport (fepABCDEG), 
7 except C. dublinensis, in which fepE is absent (Table 4). A l l Cronobacter species except C. 
8 muytjensii also possess a complete operon for aerobactin synthesis iucABCD and its receptor iutA. 
9 The operon for salmochelin synthesis is missing in all Cronobacter species (Table 4). The strong 
10 genetic similarity between C. sakazakii and Citrobacter koseri, as well as urinary pathogenic E. coli is 
11 evident from the presence of all genes for enterobactin and aerobactin synthesis in these organisms. C. 
12 sakazakii can cause urinary tract infections, though to date this aspect has not been studied in any 
13 detail. 
14 The route of infection is probably through attachment and invasion of the intestinal cells, and 
15 therefore genes encoding surface appendages such as pili (fimbriae) have been studied. Four putative 
16 fimbriae clusters were identified in the genome of C. sakazakii BAA-894, some of which were 
17 mentioned previously in (Healy, Huynh et al. 2009). These are Cluster 1 (ESA_01976 - ESA_01970), 
18 cluster 2 (ESA_02538 - ESA_02542), cluster 3 (ESA_02795 - ESA_02799) and cluster 4 
19 (ESA_04067 - ESA_04073) (Table 3). Further analysis of the comparative hybridization data 
20 showed that three of the four putative fimbrial clusters (Clusters 2, 3 and 4) were C. sakazakii 
21 specific, i.e. were classified as present or intermediate in all five strains of C. sakazakii, but were 
22 absent in C. muytjensii, C. dublinensis, C. turicensis, and C. malonaticus. Cluster 1 was present only 
23 in the reference strain and C. sakazakii strain 2, which suggests that it is strain specific. The genetic 
24 content of all fimbriae clusters was most similar to the type I chaperone/usher-assembled pilus system 
25 as defined in (Kline, Dodson et al. 2010). Genes for pilin FimA, chaperone FimC and usher FimD 
26 have been found in all four putative fimbriae clusters. These clusters may encode complete and 
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1 functional pili, as some degree of homology was found between the other genes in the C. sakazakii 
2 fimbriae clusters and the remaining components necessary for type-I pilus assembly (the minor tip 
3 fibrillum FimG and fimbrial adhesin FimH). The presence of the putative fimbriae clusters in 
4 Cronobacter species according to the C G H data is summarised in Table 3. 
5 Type VI secretion system (T6SS) is a newly described system that may be involved in adherence, 
6 cytotoxicity, host-cell invasion, growth inside macrophages and survival within the host. Five putative 
7 T6SS clusters were identified in the genome of C. sakazakii BAA-894, some of which were 
8 mentioned in (Kucerova, Clifton et al. 2010). Cluster 1 (ESA_00140 - ESA_00145) encodes most of 
9 the proteins that are conserved across different T6SS clusters (a DotU homolog ESA_00141, Vgr 
10 homolog ESA_00141 and a putative lipoprotein from the VC_A0113 family ESA_00145). However, 
11 most T6SS clusters typically encode from 12 to 25 proteins (Filloux, Hachani et al. 2008) and also 
12 encode a ClpV ATPase, which was not found in this cluster. In some instances, the genes encoding 
13 Vgr and DotU proteins are located outside the main T6SS locus, and their products might cooperate 
14 with proteins encoded in other loci. Cluster 2 (ESA_02035 - ESA_02040) includes genes encoding a 
15 Vgr-type protein (ESA_02035), lipoprotein from VC_A0113 family ESA_02038 and other genes 
16 homologous to proteins encoded in T6SS clusters. Cluster 3 (ESA_02735 - ESA_0240) contains 
17 genes encoding SciE-type protein (ESA_02736), Vgr-type protein (ESA_02739) and a protein 
18 homologous to phage gp7 protein, all of which are frequently found in T6SS clusters. However, this 
19 cluster is adjacent to a prophage fragment described in (Kucerova, Clifton et al. 2010) and due to the 
20 sequence similarities between T6SS and prophages it is difficult to conclude whether this cluster is a 
21 part of a T6SS. Cluster 4 (ESA_03899 - ESA_03946) is the longest and the most complete cluster of 
22 T6SS genes. Its 48 genes include all the components of T6SS typically conserved among different 
23 T6SS systems, such as genes encoding Vgr-type proteins (ESA_03905 and ESA_03917), IcmF-type 
24 protein (ESA_03945), DotU-type protein (ESA_03946), ClpV ATPase (ESA_03921), SciE-type 
25 protein (ESA_03925), Ser/Thr protein phosphatase (ESA_03927) and Ser/Thr protein kinase 
26 (ESA_03920). This cluster may encode a complete and functional T6SS. Cluster 5 
27 (ESA_pESA3p05491 - ESA_pESA3p05506) encodes another putative T6SS cluster encoding some of 
29 
1 the conserved T6SS proteins. ESA_pESA3p05494 encodes DotU-like protein, ESA_pESA3p05495 
2 encoded a protein with a C-terminal extension with similarity to OmpA, a protein strongly associated 
3 with virulence properties of Cronobacter . ESA_pESA3p05497 encodes a ClpV ATPase and 
4 ESA_pESA3p05500 encodes a Vgr-like protein. The Clusters 1-5 described here are putative T6SS 
5 clusters. It remains to be determined whether they encode functional type VI secretion systems or 
6 functional components of these. 
7 
8 Summary 
9 The FAO/WHO 2004 expert committee recommended that research should be promoted to gain a 
10 better understanding of the ecology, taxonomy, virulence and other characteristics of Cronobacter. 
11 This has largely been undertaken by groups around the world. By understanding the organism better, 
12 improved detection systems have been designed and commercialized. Currently microbiological 
13 criteria for Cronobacter spp. are required for infant formulas with an intended target age <6 months. 
14 A presence/absence test is applied to large volumes due to the low (<1 cfu/g) incidence of the 
15 organism in the product. Although the organism has been recovered from follow up formulas (infant 
16 formulas with intended target age >6 months) and weaning foods, there is currently insufficient 
17 epidemiological evidence to support the implementation of criteria for these products. Readers should 
18 consult the relevant Codex (2008) documents for details. With respect to clinical sources, M L S T has 
19 revealed the organism is highly clonal and sources other than infant formula need to be considered; 
20 especially as a number of neonatal cases not attributable to PIF have been reported. Cronobacter does 
21 cause infections in all age groups. It is found in a wide range of foods, especially those of plant 
22 origin. While fortunately Cronobacter rarely causes severe meningitic and NEC infections, the 
23 heightened interest in the organism has resulted in improved regulatory control of products for the 
24 neonates and infants, as well as improved hygienic practices. Together these will reduce the risk of 
25 Cronobacter infection. 
26 
30 
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1 Table 1 Cronobacter species groupings, updated from (Baldwin, Loughlin et al. 2009). 
2 
Cronobacter species 16S cluster Biotypes M L S T sequence types 
1,2-4,8,9,12-18,20-
23,31,40,41,45,47,50,52 
7,10,11,25,26,29,53 
5,19,24,32,35,37 
28,33,34,44,49 
27,36,38,39,42,43,46 
48,51,54 
3 
4 
5 
C. sakazakii 
C. malonaticus 
C. turicensis 
C. muytjensii 
C. dublinensis 
Cronobacter genomospecies 1 
1 1,2-4,7,8,11,13 
1 5,9,14 
2 16 
3 15 
4 6,10,12 
4 16 
1 
2 
3 
Table 2 Distribution of gene clusters across the Cronobacter genus 
4 
5 
6 
7 
Gene loci Description 
ESA00257 - ESA00258 Toxin/antitoxin RelE/RelB 
ESA01116 - ESA01119 ABC-type multidrug efflux 
ESA01448 -ESA01450 Fatty acid desaturases 
ESA02125 - ESA02129 Ecotin (ESA02129) 
E S A 0 2 5 3 8 - E S A 0 2 5 4 2 Fimbriae 
ESA02544 - ESA02547 Beta-glucosides metabolism 
ESA02549 - ESA02553 Multidrug efflux system 
ESA02616 - ESA02618 Mannosyl-D-glycerate uptake 
ESA02795 - ESA02799 Fimbriae 
ESA03301 - ESA03320 Mannose metabolism 
ESA03609 - ESA03613 Mannose metabolism 
ESA04067 - ESA04073 Fimbriae 
ES A04101 - ESA04106 Cell wall biogenesis 
C. sakazakii (n=6) 
Y E S 
Y E S 
Y E S 
Y E S 
Y E S 
Y E S 
Y E S 
Y E S 
Y E S 
Y E S 
Y E S 
Y E S 
Y E S 
C. malonaticus 
N O 
N O 
N O 
Y E S 
N O 
Y E S 
Y E S 
Y E S 
N O 
N O 
N O 
N O 
N O 
1
 The presence/absence status in Cronobacter species relates to the gene for ecotin 
2
 See main text for details about absence/presence o f particular genes from this cluster 
37 
\ turicensis 
N O 
N O 
Y E S 
NO 1 
N O 
N O 
Y E S 
N O 
N O 
N O 
N O 
N O 
Y E S 2 
C. muytjensii 
N O 
N O 
Y E S 
NO 1 
N O 
Y E S 
N O 
Y E S 
N O 
N O 
N O 
N O 
Y E S 2 
C. dublinensis 
N O 
N O 
Y E S 
NO 1 
N O 
Y E S 
Y E S 
Y E S 
N O 
N O 
N O 
N O 
Y E S 2 
38 
1 Table 3 C. sakazakii BAA-894 fimbrial clusters and their presence in other Cronobacter strains 
Locus tag 
ESA01976 
ESA_01975 
ESA01974 
ESA_01973 
ESA_01972 
ESA01971 
ESA_01970 
ESA_02538 
ESA_02539 
ESA_02540 
ESA02541 
ESA_02542 
ESA_02799 
ESA_02798 
ESA_02797 
ESA_02796 
ESA_02795 
ESA_04067 
ESA04068 
ESA04069 
ESA_04070 
ESA_04071 
ESA_04072 
ESA_04073 
2 Footnote: : 
3 Absent. 
Gene Product 
Pilin FimA 
Chaperone FimC 
Usher FimD 
Pilin FimA 
Pilin FimA 
Pilin FimA 
Pilin FimA 
Pilin FimA 
Chaperone FimC 
Usher FimD 
Pilin FimA (FimH) 
Putative minor component FimG 
Putative fimbrial protein 
Chaperone FimC 
Usher FimD 
Pilin FimA 
Fimbrial protein 
Putative fimbrial protein 
Fimbrial protein 
Fimbrial protein 
Fimbrial protein 
Usher FimD 
Chaperone FimC 
Fimbrial protein 
l 1 
-1 
-1 
-1 
-1 
-1 
-1 
-1 
l 2 
0 
1 
1 
1 
1 
1 
1 
1 
1 
0 
-1 
0 
0 
1 
1 
0 
C. sakazakii strain number, see (Kucerova, 
2 
1 
0 
Clifton 
C. sakazakii 
20 701 
-1 -1 
-1 -1 
-1 -1 
-1 -1 
-1 -1 
-1 -1 
-1 -1 
1 0 
0 0 
0 -1 
etal.2010)foi 
767 696 
C. malonaticus C. turicensis C. muytjensii C. dublinensis 
0 0 
-1 -1 
s. 2 According to C G H analysis 1= Present, 0 = Intermediate, -1 
39 
Table 4 Iron uptake systems in C. sakazakii BAA-894 and other Cronobacter strains. 
Gene Esak homologue (BLAST) Locus Tag C. sakazakii 2 20 701 767 696 C. malonaticus C. turicensis C. muytjensii C. dublinensis 
Enterobactin synthesis - non ribosomal peptide synthesis pathway 
e f )fA 2,3-dihydroxybenzoate-2,3-dehydrogenase 
en(B hypothetical protein ESA_00798 
en(Q hypothetical protein ESA_00796 
entQ hypothetical protein ESA_02731 
ent£ enterobactin synthase subunit E 
entf enterobactin synthase subunit F 
entQ enterobactin exporter EntS 
Enterobactin receptor and transporters 
/epA outer membrane receptor FepA 
fepB iron-enterobactin transporter 
fepQ hypothetical protein ESA_00791 
fepQ iron-enterobactin transporter 
fepE ferric enterobactin transport protein FepE 
fepQ iron-enterobactin transporter permease 
Salmochelin synthesis 
iroB salmochelin siderophore system 
iroC salmochelin siderophore system 
iroQ enterobactin/ferric enterobactin esterase 
iroE IroE protein 
/ r oN outer membrane receptor FepA 
Aerobactin synthesis and receptor 
/UCA hypothetical protein ESA_pESA3p05547 
/UCB hypothetical protein ESA_pESA3p05548 
jucC hypothetical protein ESA_pESA3p05549 
/UCD hypothetical protein ESA_pESA3p05550 
/ufA hypothetical protein ESA_pESA3p05551 
ESA_00799 
ESA_00798 
ESA_00797 
ESA_02731 
ESA_02729 
ESA_02727 
ESA_00794 
ESA_02730 
ESA_00796 
ESA_00791 
ESA_00793 
ESA_00459 
ESA_00792 
No match 
No match 
No match 
No match 
ESA_01552 
ESA_pESA3p05547 
ESA_pESA3p05548 
ESA_pESA3p05549 
ESA_pESA3p05550 
ESA_pESA3p05551 
1 
0 
0 
NA 
NA 
NA 
NA 
1 
1 
1 
0 
1 
1 
NA 
NA 
NA 
NA 
1 
1 
1 
0 
1 
1 
1 
1 
0 
1 
0 
0 
1 
1 
1 
1 
0 
1 
0 
NA 
NA 
NA 
NA 
1 
0 
0 
0 
0 
1 
1 
1 
0 
1 
0 
0 
1 
1 
1 
1 
0 
1 
1 
NA 
NA 
NA 
NA 
1 
0 
0 
0 
0 
1 
0 
NA 
NA 
NA 
NA 
1 
1 
0 
0 
1 
1 
1 
1 
0 
0 
1 
0 
1 
1 
0 
0 
0 
1 
0 
NA 
NA 
NA 
NA 
1 
1 
0 
0 
1 
1 
1 
1 
1 
0 
0 
1 
1 
1 
1 
1 
1 
0 
1 
NA 
NA 
NA 
NA 
0 
0 
1 
NA 
NA 
NA 
NA 
0 
1 
1 
1 
1 
0 
0 
1 
1 
0 
0 
0 
1 
1 
1 
1 
1 
0 
1 
NA 
NA 
NA 
NA 
1 
NA 
NA 
NA 
NA 
1 
1 
1 
0 
1 
0 
40 
3 
4 
Other iron uptake genes 
feQ enterobactin/ferric enterobactin esterase 
fhuk ferrichrome outer membrane transporter 
fhuB iron-hydroxamate transporter permease 
fhuD iron-hydroxamate transporter 
fpVj\ ferrichrome outer membrane transporter 
fur ferric uptake regulator 
/bpA heat shock protein IbpA 
//jpB heat shock chaperone IbpB 
No match 
ESA_03190 
ESA_03187 
ESA_03188 
No match 
No match 
ESA_03960 
ESA 03959 
NA 
1 
1 
1 
NA 
NA 
1 
1 
NA 
1 
1 
1 
NA 
NA 
1 
1 
NA 
1 
1 
1 
NA 
NA 
1 
1 
NA 
1 
1 
1 
NA 
NA 
1 
1 
NA 
1 
1 
1 
NA 
NA 
0 
1 
NA 
-1 
0 
1 
NA 
NA 
1 
1 
NA 
1 
1 
1 
NA 
NA 
1 
1 
NA 
0 
1 
1 
NA 
NA 
1 
1 
NA 
-1 
1 
1 
NA 
NA 
1 
1 
NA 
1 
1 
1 
NA 
NA 
1 
1 
Footnote: : C. sakazakii strain number, see (Kucerova, Clifton et al. 2010) for details 2 According to C G H analysis 1= Present, 0 = Intermediate, -1 = Absent. 
re 1. 16S rDNA gene neighbour joining phylogenetic tree of Cronobacter genus. 
H 
r 
f 
M: 
C.sakazakii 
C.sakazakii 
C.sakazakii 
C.sakazakii 
C.sakazakii 
C.sakazakii 
C.sakazakii 
C.sakazakii 
C.sakazakii 
C.sakazakii 
C.sakazakii 
C.sakazakii 
C.sakazakii 
C.sakazakii 
C.sakazakii 
C.sakazakii 
C.sakazakii 
C.sakazakii 
C.sakazakii 
C.sakazakii 
C.sakazakii 
C.malonaticus 
C.rnalonaticus 
C.malonaticus 
C.rnalonaticus 
C.malonaticus 
C.muytjensii 
C.muytjensii 
C.muytjensii 
C.tuhcensis 
C.turicensis 
C.tuhcensis 
C.dublinensis 
C.dublinensis 
42 
1 Figure 2. Mulitlocus sequence typing (7 loci, 3036 nt) gene neighbour joining phylogenetic tree of 
2 Cronobacter genus. 
3 
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I ST1 Csakazakii 
ST14 Csakazakii 
— ST12 Csakazakii 
I ST41 Csakazakii 
ST52 Csakazakii 
- ST8 Csakazakii 
ST22 Csakazakii 
I— ST18 Csakazakii 
J > ST23 Csakazakii 
ST17 Csakazakii 
r- ST3 Csakazakii 
L ST9 Csakazakii 
ST13 Csakazakii 
~ ST50 Csakazakii 
— ST47 Csakazakii 
, ST4 Csakazakii 
1-ST15 Csakazakii 
— ST20 Csakazakii 
— ST21 Csakazakii 
- ST16 Csakazakii 
— ST31 Csakazakii 
j ST40 Csakazakii 
ST45 Csakazakii 
ST25 Cmalonaticus 
I ST7 Cmalonalicus 
' ST29 Cmalonaticus 
r- ST10 Cmalonaticus 
I— ST53 Cmalonaticus 
CST11 Cmalonaticus ST26 Cmalonaticus 
I— ST51 Cgenomosppl 
I— ST54 Cgenomosppl 
— ST48 Cgenomosppl 
I ST5 Ctuncensis 
P ST35 Ctuflcensis 
I SI 
^ 
T32 Cturiconsis 
ST19 Cturicensis 
ST24 Cturicensis 
ST37 Quricensls 
— ST27 Cduolinensis 
• ST46 Cdublmensis 
ST36 Cdubtinensis 
- ST43 Cdublmensis 
ST42 Cdublinensis 
KST38 Cdublinensis ST39 CduWinensis 
• ST33 Cmuytjensii 
ST34 Cmuy liens il 
• ST28 Cmuytjensii 
• ST44 Cmuytjensii 
• ST49 Cmuytjensii 
r x« 
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1 
